-- 
Israeli Stocks: BioLineRx, Koor, Partner, Teva, Magal Systems

-- B y   S h o s h a n n a   S o l o m o n
-- 
2011-09-14T14:42:17Z

-- http://www.bloomberg.com/news/2011-09-14/israeli-stocks-biolinerx-koor-industries-teva-magal-security.html
Israel ’s TA-25 Index advanced to
the highest level in almost a week, gaining 1.6 percent to
1,036.50 at the 4:30 p.m. close in  Tel Aviv . Investors traded
about 1.76 billion shekels ($473 million) of shares and
convertible securities, according to the Tel Aviv Stock Exchange
data.  The following stocks rose or fell today. Symbols are in
parentheses.  BioLineRx Ltd. (BLRX IT) soared the most since July 3,
climbing 13 percent to 1.276 shekels. Preliminary results of a
Phase I study for an orally taken molecule for neuropathic pain
showed it was safe and well tolerated, the biopharmaceutical
company said.  EZchip Semiconductor Ltd. (EZCH)   surged to the highest
since at least April 2002, when Bloomberg began tracking the
stock, gaining 6.5 to 130.40 shekels. Shares of the maker of
network processors have climbed 17 percent in Tel Aviv over the
past two days amid speculation Marvell Technology Group will buy
the Israeli company to stave off competition.  Koor Industries Ltd. (KOR)   advanced the most in a month,
surging 15 percent to 34.60 shekels.  Discount Investment Corp. (DISI) 
 offered to buy 3.3 million shares, or 7 percent of the
holding company, at 35 shekels each. Discount shares gained 6
percent, the most since Aug. 29, to 27.91 shekels.  Magal Security Systems Ltd. (MAGS)   declined to the
lowest since at least July 2001, when Bloomberg began tracking
the stock, tumbling 11 percent to 7.66 shekels. The maker of
computerized security systems will delist from the Tel Aviv
Stock Exchange on Dec. 1.  Partner Communications Co. (PTNR IT) climbed the most in a
week, adding 2.8 percent to 36.30 shekels. The country’s second-
largest mobile-phone operator named Haim Romano chief executive
officer, replacing Yacov Gelbard.  Teva Pharmaceutical Industries Ltd. (TEVA)   rose the most
in a week, increasing 2.4 percent to 143 shekels. The world’s
largest maker of generic drugs will invest $19 million in the
CureTech Ltd. unit of  Clal Biotechnology Industries Ltd. (CBI)  . Clal gained 5 percent, the most since Sept. 1, to 15.57
shekels.  To contact the reporter on this story:
Shoshanna Solomon in Tel Aviv at 
 ssolomon22@bloomberg.net   To contact the editor responsible for this story:
Claudia Maedler at 
 cmaedler@bloomberg.net  